BIOPHARMA
By
Is Merck’s $10B Acquisition of Verona a Strategic Masterstroke to Offset Keytruda’s Patent Cliff and Dominate the $30B+ Respiratory Market?
Key Highlights Merck Secures Verona to Bridge Its Post-Keytruda Future Merck & Co. has taken a bold step…
Can Google DeepMind’s Isomorphic Labs Revolutionize Clinical Trials with AI-Designed Drugs Backed by $600M and AlphaFold Breakthrough?
Key Takeaways AI to Clinic: Isomorphic Labs Moves Beyond Design to Human TrialsIsomorphic Labs, the AI drug discovery…
Five Breakthrough AI Innovations Set to Transform Healthcare in 2025
The healthcare industry is poised for a major transformation in 2025 as artificial intelligence (AI) technologies continue to…
Biomni AI Agent Unveils New Era in Biology Research with Claude 4 Sonnet Integration and Extensive Toolset
A groundbreaking advancement in life sciences research has arrived with the launch of Biomni, a state-of-the-art AI agent…
Can Roche’s $700M Genentech Facility Drive Its $50B US Investment Strategy and Transform Obesity Drug Manufacturing?
Key Highlights Strategic Expansion into US ManufacturingGenentech, Roche’s US subsidiary, has broken ground on a new $700M state-of-the-art…
Can Novartis and BioArctic’s $802M Alliance Unlock the Next Breakthrough in Neurodegenerative Drug Delivery?
Key Highlights Strategic Collaboration Targets Neurodegenerative DiseasesNovartis has entered into a research partnership with Sweden’s BioArctic, committing $30M…
